Global Nonvascular Interventional Radiology Device Market Size By Type (Sutures, Catheterization Sets), By Application (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Nonvascular Interventional Radiology Device Market was valued at USD 5.2 billion in 2023 and is projected to reach USD 8.4 billion by 2031, growing at a CAGR of 6.2% from 2023 to 2031. This market is witnessing growth due to the rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and the advancement of image-guided interventions. Nonvascular interventional radiology involves procedures performed outside the vascular system, often targeting organs such as the lungs, kidneys, and liver, with tools like biopsy needles, drainage catheters, and ablation devices.

Drivers:

1. Increasing Demand for Minimally Invasive Procedures:

Patients and healthcare providers are shifting towards less invasive alternatives due to shorter recovery times, reduced hospital stays, and lower complication rates. This trend significantly supports the demand for nonvascular interventional radiology devices.

2. Technological Advancements in Imaging and Guidance Systems:

Integration of real-time imaging technologies such as ultrasound, CT, and MRI enhances procedural precision and outcomes. Innovations in navigation and needle tracking systems are further expanding procedural capabilities.

3. Rising Burden of Chronic Diseases:

An increase in the incidence of conditions such as cancer, kidney diseases, and hepatobiliary disorders has led to a surge in image-guided diagnostic and therapeutic procedures.

Restraints:

1. High Cost of Interventional Radiology Equipment:

The upfront cost of advanced imaging and procedural systems can be a barrier for small- and medium-sized healthcare facilities, especially in developing nations.

2. Shortage of Skilled Radiologists:

A growing demand for interventional procedures contrasts with a global shortfall of trained interventional radiologists, hindering the full adoption of these technologies.

Opportunity:

1. Growing Adoption in Emerging Markets:

Rapid healthcare infrastructure development and increasing healthcare investments in countries across Asia-Pacific and Latin America present strong growth prospects for market expansion.

2. Expansion of Outpatient and Ambulatory Surgery Centers:

The rise of ambulatory care centers, which favor minimally invasive treatments, is expected to propel the demand for compact, efficient, and cost-effective nonvascular interventional radiology tools.

Market by System Type Insights:

Based on system type, Biopsy Needles accounted for the largest market share in 2023. These devices are essential for obtaining tissue samples in cancer diagnostics and other pathological conditions. However, Ablation Devices are projected to exhibit the highest CAGR over the forecast period due to rising adoption in tumor and fibroid treatments.

Market by End-use Insights:

By end use, Hospitals emerged as the largest segment in 2023, supported by comprehensive diagnostic and interventional capabilities. Diagnostic Imaging Centers are expected to witness the fastest growth due to their growing adoption of minimally invasive procedures and ability to offer cost-effective services.

Market by Regional Insights:

North America led the global market in 2023, driven by well-established healthcare systems, high healthcare expenditure, and early adoption of advanced interventional technologies. Meanwhile, the Asia-Pacific region is forecasted to grow at the fastest rate, owing to a growing patient population, increased investment in healthcare infrastructure, and an expanding base of trained interventional radiologists.

Competitive Scenario:

Key players in the global nonvascular interventional radiology device market include:

BD (Becton, Dickinson and Company)

Cook Medical

Boston Scientific Corporation

Medtronic

Teleflex Incorporated

AngioDynamics

Argon Medical Devices

Merit Medical Systems

Olympus Corporation

Siemens Healthineers

These companies focus on strategic product launches, mergers and acquisitions, and geographic expansion. Notable developments include:

2023: BD launched a next-generation core biopsy device tailored for real-time ultrasound guidance.

2024: Medtronic partnered with a leading imaging company to integrate AI-assisted planning into nonvascular interventional procedures.

2025: Merit Medical Systems expanded its manufacturing capacity in the Asia-Pacific region to meet growing regional demand.

Scope of Work – Global Nonvascular Interventional Radiology Device Market

Report Metric Details

Market Size (2023) USD 5.2 billion

Projected Market Size (2031) USD 8.4 billion

CAGR (2023–2031) 6.2%

Market Segments By System Type, End-Use, Region

Growth Drivers Demand for minimally invasive procedures, Technological innovation

Opportunities Expansion in emerging markets, Growth of outpatient procedures

Key Market Developments:

March 2023: Boston Scientific launched an innovative radiofrequency ablation system for soft tissue tumors with enhanced safety features.

August 2024: Olympus Corporation announced a new range of image-guided biopsy devices with real-time feedback mechanisms.

January 2025: AngioDynamics introduced a cryoablation catheter optimized for use in outpatient care settings, focusing on renal and hepatic applications.

FAQs:

1) What is the current market size of the Global Nonvascular Interventional Radiology Device Market?

The market size in 2023 is valued at USD 5.2 billion.

2) What is the major growth driver of the Global Nonvascular Interventional Radiology Device Market?

The major growth driver is the increasing demand for minimally invasive and image-guided procedures.

3) Which is the largest region during the forecast period in the Global Nonvascular Interventional Radiology Device Market?

North America is the largest region by market share, while Asia-Pacific is the fastest-growing.

4) Which segment accounted for the largest market share in Global Nonvascular Interventional Radiology Device Market?

The Biopsy Needles segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Nonvascular Interventional Radiology Device Market?

Key players include BD, Cook Medical, Boston Scientific, Medtronic, and Teleflex, among others.